Incidence & Predictors of Treatment Failure for Bacterial Vaginosis JM Marrazzo, KK Thomas, K Ringwood, T Fiedler, DN Fredricks University of Washington.

Slides:



Advertisements
Similar presentations
Transmission of Chlamydia trachomatis between heterosexual sex partners PRELIMINARY RESULTS FROM A GENOTYPE-SPECIFIC CONCORDANCE STUDY.
Advertisements

Repeat Chlamydia trachomatis: Rate and Predictors among Males Eileen F. Dunne M.D., M.P.H. JB Chapin, C Rietmeijer, CK Kent, J Ellen, C Gaydos, N Willard,
Repeat Infections among Adolescents and Young Adults: Findings From Philadelphia STD Clinics Nicole Liddon, PhD 1 Michael Eberhart, BS 2 Jami Leichliter,
Persistence of HPV in a cohort of female adolescents Erika Samoff, Emilia H. Koumans, Lauri E. Markowitz, Maya Sternberg, Mary K. Sawyer, David Swan, John.
Bacterial Vaginosis and Pregnancy : Clinical Overview and Public Health Implications Deborah B. Nelson, Ph.D. Assistant Professor Center for Clinical Epidemiology.
STD Screening in HIV Clinics: Value and Implications Thomas Farley, MD MPH Tulane University Deborah Cohen, MD MPH RAND Corporation.
Printed by Comparison of Primary Care and Clinical Laboratory Methods for the Diagnosis of Bacterial Vaginosis and Yeast Vaginitis.
Self-Collected Vaginal Specimens for the Detection of Multiple STIs in Adolescent Detainees Cynthia M. Holland, M.D., M.P.H., Harold C. Wiesenfeld, M.D.,
PID Evaluation and Clinical Health (PEACH) Study.
Treating Students with Urinary Tract Infections
Behavioral Intention and Partner Type on Condom Use Among Men in Drug Treatment Yong S. Song, PhD, University of California, San Francisco Donald Calsyn,
C. Andres Bedoya, PhD Behavioral Medicine Service Department of Psychiatry Massachusetts General Hospital / Harvard Medical School Factors related to high-risk.
A comparison of three different strategies to treat partners of men with urethritis Patty Kissinger 1 Gwangi Richardson-Alston 1 Jami S Leichliter 4 Hamish.
Repeat Chlamydial Infections in Region III Family Planning Clinics: Implications for Screening Programs Pamela G. Nathanson, Family Planning Council, Inc.
Behavioral and Demographic Risk Factors for Bacterial Vaginosis among Wyoming Women Presented by Jennifer Chase, MS 12 th Annual Maternal & Child Health.
Recurrent PID, Subsequent STI, and Reproductive Health Outcomes: Findings from the PID Evaluation and Clinical Health (PEACH) Study Maria Trent, MD, MPH.
HIV INTERVENTION FOR PROVIDERS (HIP) Principal Investigators:  Carol Dawson Rose, RN, Ph.D. and Grant Colfax, MD. Co-Investigators:  Cynthia Gomez, Ph.D.,
Sexual Risk Behaviors of Self- identified and Behaviorally Bisexual HIV+ Men. By: Matt G. Mutchler, PhD; Miguel Chion, MD, MPH; Nancy Wongvipat, MPH; Lee.
The laboratory investigation of urinary tract infections
Pelvic Inflammatory Disease (PID) Natasha Lomax Tamika Missouri Monique Veney.
Risk factors for Incident Trichomonas vaginalis among Women Recruited in RESPECT-2, an HIV Prevention Trial D Helms 1, D Mosure 1, T Peterman 1, C Metcalf.
1 Suppressive Valacyclovir Therapy Soon After Initial Genital Herpes: Clinical Efficacy and Impact on Herpes-Related Quality of Life Hunter Handsfield.
Nuanced seroadaptive behaviors among Seattle MSM: sexual decision- making based on ART use/viral load and recency of partner HIV testing Christine M. Khosropour,
Patterns of Age Mixing and Sexually Transmitted Infections Julie Kraut-Becher University of Pennsylvania Sevgi O. Aral Division of STD Prevention, CDC.
Sexual Risk Behaviors and Sexually Transmitted Infection (STI) Prevalence in an Outpatient Psychiatry Clinic LH Bachmann 1,2, J Feldman 1, Y Waithaka 1.
PROMISCUOUS SEXUAL ACTIVITY IS ASSOCIATED WITH BACTERIAL VAGINOSIS IN YOUNG WOMEN WHO DOUCHE MK Oh, J Schwebke, J Merchant, P Brown, R Desmond, M Jones,
EVOLUTION OVER TIME – LOW RISK GROUP -The presence or absence of a particular Lactobacillus species appeared to remain constant throughout the study (Figure.
Quality of Life and Depression as Determinants of Treatment Adherence in Hypertensive Leonelo E. Bautista 1 ; Paul Smith 2 ; Cynthia Colombo 2 ; Dennis.
Racial Disparities in Antiretroviral Therapy Use and Viral Suppression among Sexually Active HIV-infected Men who have Sex with Men— United States, Medical.
Demonstration of a Process- Outcome Link for Smoking Cessation Melissa M. Farmer, PhD 1,2 Elizabeth M. Yano, PhD 1,2 Brian S. Mittman, PhD 1,2 Scott E.
Genital Human Papillomavirus Infection: Incidence and Risk Factors in a Cohort of Female University Students R.L. Winer, Shu-Kuang Lee, J.P. Hughes, D.
TEAM CASE STUDY 3. EUKARYOTIC – PROTOZOA.
Background There is uncertainty regarding the frequency, predictors, and outcomes of IRIS events Prior studies on IRIS have been limited to convenience.
Effects of an HIV/AIDS peer prevention intervention on sexual and injecting risk behaviors among injecting drug users (IDUs) and their risk partners in.
作者 : 作者 : Sophie Coudeyras, Gwendoline Jugie, [...], and Christiane Forestier 日期 :
Gonorrhea Increases In Washington State: Gonorrhea Increases In Washington State: Analyses for intervention planning May 2011 Mark R. Stenger Infectious.
Neurocognitive Impairment in HIV-Infected Subjects on HAART: Prevalence and Associations Kevin Robertson *1, Kunling Wu 2, Thomas Parsons 1, Ron Ellis.
Relationship Power & Sexual Risk in a Sample of Drug-Involved Women Aimee Campbell, MSSW Columbia University School of Social Work Social Intervention.
Lipoatrophy and lipohypertrophy are independently associated with hypertension: the effect of lipoatrophy but not lipohypertrophy on hypertension is independent.
Evaluation of Presumptive Treatment Recommendation for Asymptomatic Anorectal Gonorrhoea and Chlamydia Infections in At-Risk Kenyan MSM IAS 24 July 2012.
BASELINE ASSESSMENT OF CHLAMYDIA REINFECTION IN REGION VIII FAMILY PLANNING CLINICS FOR Hamby, Y, JSI Research & Training Institute Donovan,
Predicting Pregnancy Risk among Women Attending an STD Clinic Judith Shlay MD, MSPH Denver Public Health September 21, 2008 CityMatCH Conference.
Bob Kirkcaldy, Nicholas Gaffga, Lori Newman
Correlates of HIV incidence among black men who have sex with men in 6 U.S. cities (HPTN 061) B. KOBLIN, K. MAYER, S. ESHLEMAN, L. WANG, S. SHOPTAW, C.
THE 6 TH NATIONAL SCIENTIFIC CONFERENCE ON HIV/AIDS Yield and impact of repeated screening for tuberculosis and isoniazid preventive therapy among patients.
1 CONFIDENTIAL – DO NOT DISTRIBUTE ARIES mCRC: Effectiveness and Safety of 1st- and 2nd-line Bevacizumab Treatment in Elderly Patients Mark Kozloff, MD.
Epidemiology of STD. Change in incidence (simple access to antibiotic, change to sexual behavior, multiple partner, low age of sexual contact, addiction,
Bacterial Vaginosis By Scott Ecker. What is bacterial vaginosis  It is the name of a condition in women where the normal in women where the normal balance.
GENITAL TRACT INFECTION Lower GTI At birth the vagina is lined by stratified sq.epith.under the influnce of maternal oestrogen. This lining is changed.
HIV in America What’s New in 2012 Christopher Hurt, MD Clinical Assistant Professor NC AIDS Education and Training Center 2012 HIV Update.
Background  Substance abusers are at risk for HIV and other STIs.  Anal intercourse (AI) is riskier than vaginal intercourse.  Studies of AI have focused.
Results from the STEAM Survey Elizabeth Barash, MPH.
NAAT identified chlamydial infections: Enhanced sensitivity, reduced transmissibility? Presenter: Maria Villarroel, MA Authors: Maria A. Villarroel, MA.
HIV Prevalence and Incidence Estimates Among Women with High Risk Indicators in Addis Ababa, Ethiopia Asfawesen G-Yohanes 1, Stephanie Combes 2, Abraham.
Associations Between Recent Gender- Based Violence and Pregnancy, Sexually Transmitted Infections, Condom Use Practices, and Negotiation of Sexual Practices.
Exploring the Role of the Microbiome in Male Genital Tract Disease Lisa E. Manhart, PhD 17 th IUSTI World Congress - Marrakech 11 May 2016.
Michael Addidle Bacterial Vaginosis. What is Bacterial Vaginosis (BV) ? Polymicrobial vaginal infection involving a reduction in the amount of Lactobacilli.
Gabriella Bathgate, Melissa Perry, John White
Previous cancer screening behavior as predictor of colon cancer screening among women aged 50 and over Rafael Guerrero-Preston DrPH, MPH APHA 135th Annual.
By Michael Albuquerque, Leo Gonzalez, Corey Leclerc
Vaginal bacteria associated with increased risk of HIV acquisition in African women McClelland RS, Lingappa J, John-Stewart G, Kinuthia, Yuhas K, Jaoko.
Conclusions & Implications
Emilia H. Koumans, Fujie Xu, Maya Sternberg, Lauri E. Markowitz
A study of high risk African American women, 15 to 21 years of age
Risks for Bacterial Vaginosis in Lesbian & Bisexual Women
K.A. Ringwood, K. K. Thomas, J.M. Marrazzo, University of Washington
The Vaginal Microbiome During Pregnancy
MTN-037 Protocol Overview
M Javanbakht, S Guerry, LV Smith, P Kerndt
MSM Attending STD Clinics HIV Testing More Frequently: Implications for HIV Prevention and Surveillance D Helms1, H Weinstock1, K Mahle1, A Shahkolahi1,2,
Presentation transcript:

Incidence & Predictors of Treatment Failure for Bacterial Vaginosis JM Marrazzo, KK Thomas, K Ringwood, T Fiedler, DN Fredricks University of Washington & Fred Hutchinson Cancer Research Center, Seattle WA

Background l Most common  Cause of vaginal symptoms prompting medical evaluation for vaginitis  Cause of vaginitis  >10% of women experience BV  May cause 11% of preterm deliveries in U.S. l Etiology not understood, but associated with douching, new male partner, unprotected sex in heterosexual women, sex between women l Frequently persists after treatment (15% - 20%) l Very frequently recurs after successful treatment (30% - 60%)  History of BV, regular partner throughout follow-up, and female partner implicated Sobel 2006; Bradshaw 2006

Background l Traditionally defined as overgrowth of commensal anaerobic flora (classically G. vaginalis, Prevotella, Mobiluncus, M. hominis) relative to H 2 O 2 + lactobacilli l Molecular (cultivation-independent) approaches have recently expanded spectrum of BV microbiology l Some bacteria highly specific for BV in recent studies l Some with known high-level resistance to metronidazole  Atopobium vaginae l “New” bacteria not yet incorporated into prospective analyses for BV persistence or recurrence Verstraelen 2004, Ferris 2004, Fredricks 2005

BV-associated bacteria (BVAB 1, 2, 3) and their relationship to bacteria in the Clostridium phylum Clostridium Cluster XIVa BVAB1 BVAB2 BVAB3

Methods l Subjects recruited to research clinic  years  Sex with woman (prior year)  Recruited through ads (self-referred) and partners l Underwent computer-assisted self-interview (CASI) at enrollment l BV diagnosed by Amsel criteria and treated with vaginal metronidazole  BV confirmed by Nugent criteria (later) l Vaginal fluid collected with polyurethane foam swab and saline lavage (0.5 cc)

Methods l All women with BV asked to return at 1 month for repeat procedures (CASI, vaginal fluid collection)  BV persistence = Nugent >6  Abnormal vaginal flora = Nugent >3 l All women asked to return at 3 months  BV recurrence defined by Nugent score >6 among women whose baseline BV was cured at 1 month

Methods Vaginal Fluid Collected at All Visits: l Traditional culture  Used to define H2O2 production by lactobacilli  Typical panel of anaerobic flora l Bacterium-specific PCR assays based on cloned 16s rDNA sequences derived from earlier analysis of clones by RFLP, sequencing; all positive results sequence-confirmed BVAB1Leptotrichia sppMobiluncus curtisii BVAB2Peptoniphilus sppMobiluncus mulieris BVAB3P. lacrimalisPrevotella G1 Megasphaera phylotype 1 (elsdensii-like) Megasphaera phylotype 2 (micronucliformis-like) Lactobacillus crispatus Lactobacillus iners Eggerthella-like uncultured bacterium Gardnerella vaginalisAtopobium spp

Results Baseline and Persistent BV 239 women enrolled BV N = 12 / 72 (17%) No BV N = 60 / 72 (83%) Characteristics: Median age 25 y Nonwhite: 25% Sex with male last 3 mos: 28% Douche last 3 mos: 6.4% At 1 month baseline N = 66 (28%) No BV N = 173 (72%) New BV during study N = % had BV at baseline Overall f/u at 1 month = 90% 83% responded to vaginal MTZ Persistent BV incidence: 17% 72 women with BV

Baseline Vaginal Microbiology (PCRs) Demographics OR (95% CI) Age y3.9 (0.9, 16.4) Black race7.0 (3.9, 12.4) P=0.15 P=0.67 P=0.009 P=0.06 OR (95% CI) BVAB1 2.3 (0.8, 6.5)) BVAB22.2 (0.3, 15.5) BVAB34.4 (1.5, 13.4) Results Factors Associated with BV Persistence Incidence of BV Recurrence (%) P=0.03

OR (95% CI) BVAB12.6 (1.3, 5.2) Adherence0.36 (0.2, 0.7) Any sex4.1 (0.6, 28) Vaginal sex2.1 (1.1, 4.2) P=0.05 *Intercourse with male partner Results Additional Factors Associated with Persistence of Abnormal Flora (N = 22) Incidence of BV Recurrence (%) P=0.02 P=0.05 P=0.09

Results Baseline and Persistent BV 239 women enrolled BV N = 12 / 72 (17%) No BV N = 60 / 72 (83%) At 1 month baseline N = 66 (28%) No BV N = 173 (72%) New BV during study N = % who initially responded to MTZ had BV recurrence 72 women with BV Recurrent BV N = 8 / 53 (15%)

Conclusions Distinct risks predict BV persistence –Demographics Black women consistently at high risk for BV –Reasons unclear; not related to douching in our study Older age –Vaginal microbiology BVAB3, possibly BVAB1 –Sex Vaginal fluid exchange, intercourse with men [Sanchez 2004, Bradshaw 2006] Further study needed –Additional accrual of subjects to substantiate preliminary trends and assess risks for BV recurrence –Cultivation of BVAB to assess pathogenicity and antibiotic susceptibilities

Limitations Small number of subjects who were self- referred or referred by partners –Limits on reproducibility, generalizability –However, excellent retention and diverse sexual practices Development of bacterium-specific PCRs directed by initial clone analysis –May not include all relevant species

Acknowledgements Study personnel Nancy Dorn Dana Varon Lauren Asaba Susan Heideke Corey Fish Kathy Agnew Becca Hutcheson Support Dave Eschenbach Sharon Hillier King Holmes Larry Corey

Associations Between Bacteria Detected and BV Bacterium-specific PCR assays for vaginal fluid samples from 40 subjects with BV and 65 without BV. ORs adjusted for age, site of enrollment, vaginal symptoms, report of sex with men